Connect with us

health

Midwives play a huge role in reducing maternal, newborn deaths in Africa-WHO

The Acting WHO Regional Director for Africa praises the critical role of midwives in maternal and newborn health, especially during crises, while highlighting the urgent need to address the 6.1 million health worker shortfall in the region.

Published

on

Midwives Critical in Africa

The Acting WHO Regional Director for Africa praises the critical role of midwives in maternal and newborn health, especially during crises, while highlighting the urgent need to address the 6.1 million health worker shortfall in the region

 

adron lemon friday

The Acting World Health Organisation (WHO) Regional Director for Africa, Dr. Chikwe Ihekweazu, has issued a strong commendation for the vital contributions of midwives across the African continent, recognizing them as the essential frontline guardians of maternal and newborn health.

Also read: First lady Oluremi Tinubu advocates for maternal, newborn health on World Health Day 2025

In a message released on Monday to commemorate the International Day of the Midwife, themed “Midwives: Critical in Every Crisis” for 2025, Dr. Ihekweazu underscored the indispensable role of midwives in navigating every type of health crisis. He also drew attention to the alarming 6.1 million health worker shortfall projected for the African region.

Dr. Ihekweazu lamented the persistently high maternal and newborn death rates in Africa, emphasizing that the dedicated efforts of midwives have been instrumental in achieving reductions in maternal mortality.

The WHO statistics reveal that over one million newborns and 178,000 mothers tragically die each year in the region.

While South Sudan faces the highest maternal mortality rate globally, Nigeria ranks third with 512 deaths per 100,000 live births.

In his message posted on the WHO website, Dr. Ihekweazu aligned the International Day of the Midwife with the momentum of World Health Day 2025 and its theme, “Healthy Beginnings, Hopeful Futures.”

He stressed that this year’s celebration is a call for greater recognition and increased investment in midwives, whom he described as “the people who make healthy beginnings possible.”

“In the African Region, where over one million newborns and 178,000 mothers die each year, midwives are a lifeline,” Dr. Ihekweazu stated.

“They deliver skilled, compassionate care across the entire continuum of reproductive and maternal health, often in the most difficult and resource-limited settings.

Their efforts have been pivotal in reducing maternal mortality, with the regional average dropping from 727 deaths per 100,000 live births in 2000, to 442 in 2023.”

He further highlighted that the 2025 theme aptly reflects the challenging realities faced by midwives who often operate within fragile health systems, conflict zones, and amidst natural disasters and pandemics.

“In many cases, they are the only providers of sexual and reproductive health services in their communities,” he added.

“In the African Region, where over one million newborns and 178,000 mothers die each year, midwives are a lifeline. They deliver skilled, compassionate care across the entire continuum of reproductive and maternal health, often in the most difficult and resource-limited settings,” said Dr. Chikwe Ihekweazu, Acting WHO Regional Director for Africa.

Despite the significant projected shortage of 6.1 million health workers in the African Region by 2030, Dr. Ihekweazu noted encouraging progress.

Between 2013 and 2022, the number of midwives nearly doubled, increasing from 173,269 to over 334,000, a testament to the impact of political will, coordinated investment, and focused strategies.

However, Nigeria is currently grappling with a significant emigration of medical practitioners, with over 7,500 nurses and midwives reportedly leaving the country in the past five years.

The National Association of Nigeria Nurses and Midwives estimated in 2023 that approximately 70,000 midwives were needed to bridge the gap created by this exodus.

Dr. Ihekweazu affirmed that the WHO continues its close collaboration with Member States to expand competency-based midwifery education, improve workforce density, and integrate midwives into national health and emergency preparedness strategies.

He cited Zimbabwe’s new Investment Compact, which will mobilize an additional $166 million annually for three years to strengthen its health workforce, with midwives at its core, as a positive example.

Despite these advancements, Dr. Ihekweazu emphasized that “still, too many midwives work without proper tools, pay, protections or opportunities for advancement.

Their voices are often excluded from the policy decisions that affect their work, and the lives of the people they serve.”

He urged governments to prioritize the integration of midwives into emergency preparedness plans, ensure their protection during crisis response, and provide them with adequate mental health resources and fair working conditions.

He also called for the evolution of education to equip midwives with essential skills in trauma-informed care, conflict sensitivity, and leadership.

“When midwives are trained, respected and empowered, health systems grow stronger, and every mother and child has a better chance at life,” Dr. Ihekweazu concluded.

“WHO stands with midwives, today and every day. Let us move beyond symbolic recognition. Let’s act, because midwives are not only critical in every crisis. They are essential to every solution.”

 

12 / 100 SEO Score

health

FCCPC Moves Against Producers Over Poorly Fortified Oil, Salt

Published

on

FCCPC orders producers to comply with food fortification standards after a survey found inadequately fortified vegetable oil and salt in Nigerian markets

(more…)

adron lemon friday

68 / 100 SEO Score
Continue Reading

health

UK Tests Five-Day Breast Cancer Radiotherapy in Major Trial

Published

on

The UK is testing five-day breast cancer radiotherapy in a major trial that could reduce hospital visits and treatment costs for patients

The United Kingdom has launched a major clinical trial involving more than 1,000 participants to determine whether breast cancer radiotherapy can be shortened from three weeks to five days without compromising its effectiveness in preventing the disease from returning.

Also read: Grey CEO Urges Africa to Ditch Dollar for Trade

adron lemon friday

The government-funded FAST-Forward Boost trial, being conducted at 39 hospitals across the UK, will investigate whether a shorter course of radiotherapy combined with an additional targeted dose, known as a boost, can provide effective treatment for patients following breast cancer surgery.

The UK Department of Health and Social Care announced the development on Friday, October 30, describing the study as part of efforts to improve cancer treatment and make care more convenient for patients.

Led by the Institute of Cancer Research in London and funded by the National Institute for Health and Care Research, the study aims to recruit 4,830 participants by 2028.

Those enrolled will be followed up for five years, with results expected in 2033.

If the approach proves successful, it could reduce the number of hospital visits required by patients, potentially saving them 10 journeys compared with the existing three-week treatment schedule.

The department said the shorter schedule could also reduce transport expenses and the time patients spend away from work and family.

It could additionally ease pressure on the National Health Service by freeing up radiotherapy capacity for other patients.

Health and Social Care Secretary Yvette Cooper said the trial reflected the country’s efforts to use medical research to improve cancer care.

“This trial shows how the UK is using our world beating research capabilities to pursue huge improvements and transformations in cancer treatment for patients,” she said.

Why the radiotherapy trial matters

Radiotherapy uses carefully targeted radiation to destroy cancer cells or prevent them from growing.

For many people with breast cancer, it is recommended after surgery to reduce the risk of the disease returning in the treated area.

A treatment boost involves delivering an additional dose of radiation to the area considered to have a higher risk of recurrence, usually the site where the tumour was removed.

The FAST-Forward Boost trial is examining how this additional treatment can be incorporated into a shorter schedule.

Reducing treatment from three weeks to five days could make a considerable difference to patients who must travel regularly to hospitals.

The impact may be particularly significant for people living far from specialist cancer centres, those with limited transport options and patients balancing treatment with employment or family responsibilities.

However, the trial is designed to establish whether the shorter approach is effective and safe for the patients being studied. Its results will be important in determining whether the treatment schedule can become a wider option in clinical practice.

UK expands breast cancer screening efforts

The announcement comes as the British government intensifies efforts to improve breast cancer screening, encourage early diagnosis and strengthen support for patients.

The Department of Health and Social Care said screening uptake among women receiving their first invitation had risen to 63.6 per cent, its highest level in a decade.

Despite the improvement, around four in 10 women invited for their first screening appointment still do not attend.

The government is also working with the National Institute for Health and Care Research and NHS England on studies examining how artificial intelligence could support the analysis of mammograms.

The technology is being explored as a way to assist the assessment of breast screening images, although its role and effectiveness must be established through appropriate research and clinical evaluation.

In addition, the government has partnered with breast cancer charity Breast Cancer Now for three years to help women recognise symptoms, find reliable information and access support after treatment.

Together, the initiatives reflect a broader approach to breast cancer care, combining screening, research into treatment improvements and support for people living with the disease.

Also read: Grey CEO Urges Africa to Ditch Dollar for Trade

For now, the five-day radiotherapy approach remains under investigation. With final results not expected until 2033, the FAST-Forward Boost trial will need to establish whether reducing treatment time can deliver comparable cancer control while maintaining patient safety.

65 / 100 SEO Score
Continue Reading

health

DR Congo Faces Deadly Ebola Surge, WHO Warns

Published

on

The DR Congo Ebola outbreak is recording 50 to 80 new confirmed cases daily, with about 10,000 cases and nearly 5,000 deaths reported

(more…)

adron lemon friday

57 / 100 SEO Score
Continue Reading

Trending News